80 results
Page 3 of 4
8-K
EX-99.1
3l1ay 9ann7vxn2
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
g2l4y44ko x89b45qjx
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
lpo356l
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
8-K
EX-99.1
1gxgbjmkx lge1giwyl6
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
8-K
EX-1.1
ckquqtodymc
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
vpvzh 4hcr8kjilbxs8
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
de1jr9 529d3c7430y6y
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
bf0rly
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.1
t9vdvcgf7tcd3
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
S-3
jijla uauurggx
1 Jun 22
Shelf registration
4:06pm
S-3
EX-1.2
0k6cn7dgj76kh 8u2k
1 Jun 22
Shelf registration
4:06pm
8-K
EX-99.1
c6f7o
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
DEF 14A
ynw mnr97vaz
28 Apr 22
Definitive proxy
4:44pm
10-K
EX-10.2
gcabz7 9evatph
7 Mar 22
Annual report
7:36am
10-K
ld7qw6xlfpqfrx ft6dz
7 Mar 22
Annual report
7:36am
8-K
EX-99.1
erk2xzx
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
8-K
70cp9rz0ijcl23x
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am
8-K
EX-99.1
lsdh r8dmuq9v
8 Nov 21
Day One Reports Third Quarter 2021 Financial Results and Corporate Progress
4:51pm